Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 19,500 shares at $3.99 ($78K) on 2017-04-20, disclosed to the SEC on 2017-04-20.
Scheduled purchase ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.98 | 4,200 | $17K | 21.5% |
| 2 | $3.98 | 4,600 | $18K | 23.6% |
| 3 | $3.99 | 5,300 | $21K | 27.2% |
| 4 | $3.99 | 5,400 | $22K | 27.7% |
| Total | $3.99 avg | 19,500 | $78K | 100% |
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |